Coapt Systems Completes $22.6 Million Series E Financing

Coapt Systems, a Palo Alto, CA, firm that develops bioabsorbable implants for aesthetic surgery, completed a $22.6 million Series E round of financing. The seven-year old company sells a range of implantable soft tissue fixation devices for use in facial plastic surgery. Its pipeline includes dermatological fillers, currently in late-stage clinical development and to be used as a complement to the fixation devices, as well as an implantable and absorbable hand tendon repair device. The new financing will support Coapt’s launch of the dermal filler products and the in-licensing of additional aesthetic products. The round was led by Easton Capital and Global Life Science Ventures; existing investors Alta Partners, Asset Management Company, Canaan Partners, Boston Millennia Partners, and Foundation Medical Partners also were involved.

The comments are closed.